MDH1
Basic information
Region (hg38): 2:63588609-63607197
Links
Phenotypes
GenCC
Source:
- developmental and epileptic encephalopathy, 88 (Limited), mode of inheritance: AR
- developmental and epileptic encephalopathy, 88 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Developmental and epileptic encephalopathy 88 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 31538237 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MDH1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 12 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 3 | |||||
Total | 0 | 0 | 13 | 6 | 0 |
Variants in MDH1
This is a list of pathogenic ClinVar variants found in the MDH1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-63588667-A-C | Bardet-Biedl syndrome | Likely benign (Jun 14, 2016) | ||
2-63589041-A-G | Likely benign (Jun 01, 2023) | |||
2-63589341-G-C | not specified | Uncertain significance (Dec 07, 2023) | ||
2-63589392-A-G | Likely benign (Mar 01, 2024) | |||
2-63594551-A-G | not specified | Uncertain significance (Mar 21, 2022) | ||
2-63595434-T-C | Likely benign (Oct 01, 2023) | |||
2-63595517-A-G | Uncertain significance (Aug 01, 2024) | |||
2-63597394-C-A | Likely benign (Jun 01, 2022) | |||
2-63597407-G-A | Uncertain significance (Jun 01, 2022) | |||
2-63597424-C-T | Likely benign (Mar 01, 2023) | |||
2-63597539-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
2-63597556-C-T | Likely benign (Sep 01, 2023) | |||
2-63597558-C-T | Developmental and epileptic encephalopathy, 88 | Pathogenic (Mar 03, 2021) | ||
2-63605301-G-A | not specified | Uncertain significance (Oct 25, 2022) | ||
2-63605370-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
2-63605391-G-C | not specified | Uncertain significance (Jan 10, 2023) | ||
2-63605954-A-G | not specified | Uncertain significance (Jul 06, 2021) | ||
2-63605964-T-C | not specified | Uncertain significance (Jan 02, 2024) | ||
2-63605996-G-C | not specified | Uncertain significance (Aug 13, 2021) | ||
2-63606007-C-T | Likely benign (Oct 01, 2022) | |||
2-63606899-A-C | not specified | Uncertain significance (Oct 12, 2021) | ||
2-63606913-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
2-63606944-C-T | not specified | Uncertain significance (May 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MDH1 | protein_coding | protein_coding | ENST00000539945 | 9 | 18589 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.928 | 0.0723 | 125741 | 0 | 7 | 125748 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.18 | 141 | 186 | 0.757 | 0.00000924 | 2298 |
Missense in Polyphen | 55 | 79.175 | 0.69467 | 941 | ||
Synonymous | 0.604 | 61 | 67.3 | 0.906 | 0.00000342 | 689 |
Loss of Function | 3.40 | 2 | 17.2 | 0.116 | 8.77e-7 | 211 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000867 | 0.0000867 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000547 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.0000547 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Citrate cycle (TCA cycle) - Homo sapiens (human);Pyruvate metabolism - Homo sapiens (human);Proximal tubule bicarbonate reclamation - Homo sapiens (human);Cysteine and methionine metabolism - Homo sapiens (human);Glyoxylate and dicarboxylate metabolism - Homo sapiens (human);Warburg Effect;Pyruvate Dehydrogenase Complex Deficiency;Transfer of Acetyl Groups into Mitochondria;Primary hyperoxaluria II, PH2;Pyruvate kinase deficiency;Leigh Syndrome;Pyruvate Metabolism;Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency);Sterol Regulatory Element-Binding Proteins (SREBP) signalling;TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc);Amino Acid metabolism;Pathways in clear cell renal cell carcinoma;Glycolysis and Gluconeogenesis;Metabolism of carbohydrates;Citrate cycle;malate-aspartate shuttle;Metabolism;TCA cycle;TCA cycle;gluconeogenesis;superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle;Gluconeogenesis;Glucose metabolism
(Consensus)
Recessive Scores
- pRec
- 0.621
Intolerance Scores
- loftool
- 0.0617
- rvis_EVS
- -0.21
- rvis_percentile_EVS
- 38.28
Haploinsufficiency Scores
- pHI
- 0.188
- hipred
- Y
- hipred_score
- 0.582
- ghis
- 0.647
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.991
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mdh1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- gluconeogenesis;tricarboxylic acid cycle;oxaloacetate metabolic process;malate metabolic process;NADH metabolic process
- Cellular component
- extracellular space;cytosol;myelin sheath;extracellular exosome
- Molecular function
- malic enzyme activity;protein binding;L-malate dehydrogenase activity;diiodophenylpyruvate reductase activity;NAD binding